We're pleased to highlight key Phase III studies and Clinical Guidelines recently published across Elsevier’s journals. Our aim is to help you and your team stay abreast of the latest influential clinical articles. Click the link next to each article to access its full-text or abstract on ScienceDirect.

To place an online order, please visit MedReprints.com, or contact me directly m.giergielewicz@elsevier.com.  

Phase III Studies 

 

Inclisiran in patients with prior myocardial infarction: A post hoc pooled analysis of the ORION-10 and ORION-11 Phase 3 randomised trials 

Atherosclerosis | October 2023 

Recommended for: Novartis 

View Article 

 

Tafamidis Efficacy Among Octogenarian Patients in the Phase 3 ATTR-ACT and Ongoing Long-Term Extension Study 

JACC: Heart Failure | November 2023 

Recommended for: Pfizer 

View Article 

 

Metoclopramide Nasal Spray in Women with Symptomatic Diabetic Gastroparesis: A Randomized, Double-blind, Placebo-controlled Phase 3 Study 

Clinical Gastroenterology and Hepatology | November 2023 

Recommended for: Ewoke Pharma 

View Article 

 

 

 

Clinical Guidelines 

 

European Society for Vascular Surgery (ESVS) 2024 Clinical Practice Guidelines on the Management of Asymptomatic Lower Limb Peripheral Arterial Disease and Intermittent Claudication 

European Journal of Vascular and Endovascular Surgery | November 2023 

Recommended for: Merck Serono - Otsuka - Bayer 

View Article 

 

CAR T-Cell therapy for Myeloma: Where are we now and what is needed to move CAR T-cells forward to earlier lines of therapy? Expert Panel Opinion from the American Society for Transplantation and Cellular Therapy

Transplantation and Cellular Therapy | October 2023 

Recommended for: Janssen - BMS 

View Article 

 

ESMO Clinical Practice Guideline interim update on the use of targeted therapy in acute lymphoblastic leukaemia 

Annals of Oncology | October 2023 

Recommended for: Roche - Amgen - Incyte - Novartis - BMS 

View Article